A therapeutic vaccine has certain requirements: it must induce Th1-type cytokines such as IFN-γ and TNF, promote the activation of infected macrophages, and prevent reactivation of latent infection and transmission of pathogens to other people (107, 108). This evidence concerns the gene TNF and disease arising from reactivation of latent virus.